KR102939516B1 - 헤테로시클릭 화합물 및 연충 감염 및 질환의 치료를 위한 그의 용도 - Google Patents

헤테로시클릭 화합물 및 연충 감염 및 질환의 치료를 위한 그의 용도

Info

Publication number
KR102939516B1
KR102939516B1 KR1020217038203A KR20217038203A KR102939516B1 KR 102939516 B1 KR102939516 B1 KR 102939516B1 KR 1020217038203 A KR1020217038203 A KR 1020217038203A KR 20217038203 A KR20217038203 A KR 20217038203A KR 102939516 B1 KR102939516 B1 KR 102939516B1
Authority
KR
South Korea
Prior art keywords
substituted
unsubstituted
mmol
piperidyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020217038203A
Other languages
English (en)
Korean (ko)
Other versions
KR20220027822A (ko
Inventor
나탈리 호릴룩
스테이시 에스. 카난
케빈 알. 콘드로스키
그레이엄 카인
매튜 베도레
산제이 메논
Original Assignee
셀진 코포레이션
조에티스 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 셀진 코포레이션, 조에티스 엘엘씨 filed Critical 셀진 코포레이션
Publication of KR20220027822A publication Critical patent/KR20220027822A/ko
Application granted granted Critical
Publication of KR102939516B1 publication Critical patent/KR102939516B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020217038203A 2019-04-26 2020-04-24 헤테로시클릭 화합물 및 연충 감염 및 질환의 치료를 위한 그의 용도 Active KR102939516B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962839552P 2019-04-26 2019-04-26
US62/839,552 2019-04-26
PCT/US2020/029805 WO2020219871A1 (en) 2019-04-26 2020-04-24 Heterocyclic compounds and their use for treatment of helminthic infections and diseases

Publications (2)

Publication Number Publication Date
KR20220027822A KR20220027822A (ko) 2022-03-08
KR102939516B1 true KR102939516B1 (ko) 2026-03-16

Family

ID=70775481

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217038203A Active KR102939516B1 (ko) 2019-04-26 2020-04-24 헤테로시클릭 화합물 및 연충 감염 및 질환의 치료를 위한 그의 용도

Country Status (6)

Country Link
US (3) US11505548B2 (cg-RX-API-DMAC7.html)
EP (1) EP3959207A1 (cg-RX-API-DMAC7.html)
JP (1) JP7546596B2 (cg-RX-API-DMAC7.html)
KR (1) KR102939516B1 (cg-RX-API-DMAC7.html)
CN (1) CN114072395A (cg-RX-API-DMAC7.html)
WO (1) WO2020219871A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021000293A (es) 2018-07-09 2021-07-15 Boehringer Ingelheim Animal Health Usa Inc Compuestos heterociclicos antihelminticos.
KR20220002890A (ko) 2019-03-19 2022-01-07 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 아자-벤조티오펜 및 아자-벤조푸란 화합물
EP3959207A1 (en) * 2019-04-26 2022-03-02 Celgene Corporation Heterocyclic compounds and their use for treatment of helminthic infections and diseases
JP2023507173A (ja) 2019-12-18 2023-02-21 インターベット インターナショナル ベー. フェー. キノリン構造を含む駆虫剤化合物
MX2022007671A (es) 2019-12-18 2022-07-19 Intervet Int Bv Compuestos antihelminticos que comprenden una estructura de azaindoles.
BR112022024156A2 (pt) 2020-05-29 2023-02-14 Boehringer Ingelheim Animal Health Usa Inc Compostos heterocílicos antelmínticos
US12655138B2 (en) 2020-07-24 2026-06-16 Elanco Us Inc. Process for making an isoxazoline compound and intermediate thereof
AU2021335500A1 (en) 2020-09-04 2023-05-04 Elanco Us Inc. Palatable formulations
WO2022087326A1 (en) * 2020-10-23 2022-04-28 Celgene Corporation Heterocyclic compounds and their use for treatment of helminthic infections and diseases
WO2022122988A1 (en) 2020-12-11 2022-06-16 Intervet International B.V. Anthelmintic compounds comprising a thienopyridine structure
CN112500324B (zh) * 2020-12-12 2022-05-13 浙江大学衢州研究院 制备硫代酰胺类化合物的方法
EP4291555A1 (en) * 2021-02-09 2023-12-20 Celgene Corporation Sulfonamides and their use for treatment of helminthic infections and diseases
WO2023073641A1 (en) 2021-11-01 2023-05-04 Boehringer Ingelheim Vetmedica Gmbh Anthelmintic pyrrolopyridazine compounds
CN115819429A (zh) * 2022-12-13 2023-03-21 成都睿智化学研究有限公司 一种5-氯-2,3-二氢呋喃[2,3-c]吡啶的合成方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005368A1 (en) 1993-08-13 1995-02-23 Zeneca Limited Thia- and oxadiazole derivatives and their use as fungicides or insecticides
WO2008126933A2 (en) 2007-04-11 2008-10-23 Sumitomo Chemical Company, Limited Process for producing pesticidal benzamide compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA879329B (en) * 1986-12-12 1988-06-13 Ciba-Geigy Ag Pesticides
EP0276432A3 (de) * 1986-12-12 1988-10-26 Ciba-Geigy Ag Schädlingsbekämpfungsmittel
US5614470A (en) * 1994-04-01 1997-03-25 Sankyo Company, Limited 13-substituted milbemycin derivatives, their preparation and their use
JP3689462B2 (ja) * 1994-11-17 2005-08-31 三共アグロ株式会社 殺虫活性を有する13位置換ミルベマイシン誘導体
CN1281127C (zh) 1995-11-08 2006-10-25 麦克公司 农药制剂
BR9611354C1 (pt) 1995-11-08 2007-06-12 Merck & Co Inc composição pesticida de gránulo solúvel, método para o controle de insetos agrìcolas, para a prevenção ou tratamento de infestações de insetos de plantas ou de produtos de plantas, e processo para a preparação de uma formulação pesticida de gránulo solúvel
DE19858193A1 (de) * 1998-12-17 2000-06-21 Aventis Cropscience Gmbh 4-Trifluormethyl-3-oxadiazolylpyridine, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
WO2000009500A2 (en) 1998-08-11 2000-02-24 Nihon Bayer Agrochem K.K. Nematicidal pyrazoles
MX2007008434A (es) * 2005-01-19 2007-07-25 Squibb Bristol Myers Co Derivados de 2-fenoxi-n-(1,3,4-tiadizol-2il)piridin-3-amina y compuestos relacionados como inhibidores del receptor p2y1 para el tratamiento de trastornos tromboembolicos.
TW201210597A (en) * 2010-06-09 2012-03-16 Gilead Sciences Inc Inhibitors of hepatitis C virus
EP2651405A2 (en) 2010-12-14 2013-10-23 Electrophoretics Limited Casein kinase 1 (ck1 ) inhibitors
EP3959207A1 (en) * 2019-04-26 2022-03-02 Celgene Corporation Heterocyclic compounds and their use for treatment of helminthic infections and diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005368A1 (en) 1993-08-13 1995-02-23 Zeneca Limited Thia- and oxadiazole derivatives and their use as fungicides or insecticides
WO2008126933A2 (en) 2007-04-11 2008-10-23 Sumitomo Chemical Company, Limited Process for producing pesticidal benzamide compounds

Also Published As

Publication number Publication date
KR20220027822A (ko) 2022-03-08
US20200339559A1 (en) 2020-10-29
US11505548B2 (en) 2022-11-22
WO2020219871A1 (en) 2020-10-29
CN114072395A (zh) 2022-02-18
EP3959207A1 (en) 2022-03-02
US20230146944A1 (en) 2023-05-11
US20250276967A1 (en) 2025-09-04
JP2022529541A (ja) 2022-06-22
US12338235B2 (en) 2025-06-24
JP7546596B2 (ja) 2024-09-06

Similar Documents

Publication Publication Date Title
JP7546596B2 (ja) ヘテロ環式化合物ならびに蠕虫感染および疾患におけるその使用
TWI453207B (zh) 胺基三唑并吡啶,其組合物及使用其之治療方法
ES2958954T3 (es) Compuestos de piridazinona y usos de los mismos
US20240025891A1 (en) Heterocyclic compounds and their use for treatment of helminthic infections and diseases
RU2448101C2 (ru) 5-замещенные изоиндолиновые соединения
US7041685B2 (en) Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
ES2380395T3 (es) Triazolopiridinas como inhibidores de fosfodiesterasa para el tratamiento de enfermedades dérmicas
JP7451569B2 (ja) ヒストン脱アセチル化酵素6阻害剤としての1,3,4-オキサジアゾールホモフタルイミド誘導体化合物、およびそれを含む薬剤学的組成物
ES2828503T3 (es) Bloqueadores de los canales de sodio, método de preparación de los mismos y uso de los mismos
KR20170036698A (ko) 항증식성 화합물 및 이의 사용 방법
BRPI0707816A2 (pt) inibidores de pi - 3 quinase e mÉtodos de uso
JP2017530199A (ja) 置換アミノプリン化合物、その組成物、及びそれによる治療の方法
CA3120667C (en) Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same
WO2014151630A2 (en) Compounds and compositions for the treatment of parasitic diseases
AU2011323899A1 (en) Methods of treatment and/or prevention of scleroderma, UV injury or sunburn, formation of scars or keloids by using haloaryl substituted Aminopurines
US20240148744A1 (en) Sulfonamides and their use for treatment of helminthic infections and diseases
KR20230127271A (ko) 헤테로시클릭 화합물 및 기생충성 질환을 위한 그의용도
WO2013115294A1 (ja) ジアザスピロウレア誘導体及びその医薬用途
HK40068974A (en) Heterocyclic compounds and their use for treatment of helminthic infections and diseases
RU2793331C1 (ru) Гомофталимидные производные 1,3,4-оксадиазола как ингибитор гистондезацетилазы 6 и содержащая их фармацевтическая композиция
CA3189672A1 (en) Copper complexes for treatment of neurodegenerative disorders
KR20240116368A (ko) 신규한 헤테로사이클릭 화합물
EA049463B1 (ru) Соединения пиридазинонов и их применения

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

D22 Grant of ip right intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D22-EXM-PE0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

F11 Ip right granted following substantive examination

Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

U12 Designation fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U12-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

Q13 Ip right document published

Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE)